The field of global health has significantly changed and expanded over recent decades, becoming increasingly linked with and central to the more traditional concerns of international relations. This volume assembles from a wide array of disciplines and fields the central works that define the field in international relations today, and explores the future of global health and the possible benefits of expanding the interdisciplinary path even further.

John J. Kirton, Professor, University of Toronto, Canada

Contents: Introduction; Part I The Foundations and Evolution of the Field: Disease, diplomacy and international commerce: the origins of international sanitary regulation in the 19th century, Mark Harrison; Origins of international health work, N. Howard-Jones; The new World Health Organization, Walter R. Sharp; World health and world politics, Charles E. Allen; The return of infectious disease, Laurie Garrett; Ghosts of Kigali: infectious disease and global stability at the turn of the century, Andrew T. Price-Smith; The politics of global health governance: whatever happened to 'health for all by the year 2000'?, Caroline Thomas and Martin Weber. Part II Globalization and Global Health: The globalization of public health: the first 100 years of international health diplomacy, David P. Fidler; Global public health: revisiting healthy policy at the global level, Ilona Kickbusch and Evelyne de Leeuw; Globalization and the prevention and control of non-communicable disease: the neglected chronic diseases of adults, Robert Beaglehole and Derek Yach; Epidemic disease and national security, Susan Peterson. Part III Communicable Disease: The lessons of the pandemic, George Soper; Communicable disease control: a 'global public good', Richard Smith, David Woodward, Arnab Acharya, Robert Beaglehole and Nick Drager; The global governance of communicable diseases: the case for vaccine R & D, Daniele Archibugi and Kim Bizzarri; Germs, governance, and global public health in the wake of SARS, David P. Fidler; Preparing for the next pandemic, Michael T. Osterholm; Should HIV/AIDS be securitized? The ethical dilemmas of linking HIV/AIDS and security, Stefan Elbe. Part IV Health and Trade: Drug development for neglected diseases: a deficient market and a public-health policy failure, Patrice Trouiller, Piero Olliaro; Els Toreele, James Orbinski, Richard Laing and Nathan Ford; Trade policy and the politics of access to drugs, Caroline Thomas; The dilemma of intellectual property rig